Guangdong Association Of Clinical Trials

This study tested a drug called camrelizumab (an immunotherapy) plus chemotherapy and radiation for people with advanced lung cancer that had spread to the brain. 60 participants who had not received prior chemotherapy were randomly assigned to receive either the camrelizumab com…

This study tested whether adding bevacizumab to erlotinib works better than erlotinib alone for people with advanced non-small cell lung cancer (NSCLC) that has certain EGFR gene mutations. About 311 Chinese adults took part. The goal was to see if the combination could delay can…